Supported by Youth Fund of National Natural Science Foundation of China,No.81803575,No.31902287;Kaifeng Science and Technology Development Plan Project,No.2203008;Key Specialized Research and Promotion Project of Henan Province in 2023,No.232102311205;Henan Medical Science and Technology Research Program Project,No.LHGJ20210801;College Students Innovation and Entrepreneurship Training Program of Henan University,No.20231022007.
BACKGROUND Trastuzumab constitutes the fundamental component of initial therapy for patients with advanced human epidermal growth factor receptor 2(HER-2)-positive gastric cancer(GC).However,the efficacy of this treat...
supported by Hong Kong Research Grants Council(SRFS2021-4S04,14112919,14164817,14109720);Hong Kong PhD Fellowship Scheme,and Health and Medical Research Fund(07181286)of China.
Atherosclerotic diseases remain the leading cause of adult mortality and impose heavy burdens on health systems globally. Our previous study found that disturbed flow enhanced YAP activity to provoke endothelial activ...
supported by grants from National Key R&D Program of China(2020YFA0707600 to Z.Z.and X.L.);the National Natural Science Foundation of China(81930063 and 81971948 to J.W.and X.L.);hinese Academy of Medical Science(CAMS)Innovation Fund for Medical Sciences(2021-I2M-1-038 to J.W.)。
Severe acute respiratory syndrome coronavirus 2(SARS‐CoV‐2)continues to evolve,generating new variants that pose a threat to global health;therefore,it is imperative to obtain safe and broad‐spectrum antivirals aga...